Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Globalization, Patents and Drugs (Second Edition). An Annotated Bibliography - Health Economics and Drugs Series No. 010
(2001; 52 pages) Ver el documento en el formato PDF
Resumen
Many WHO Member States have expressed concern about the effects of the TRIPS Agreement on access to pharmaceuticals and, in May 1999, the World Health Assembly mandated WHO “to cooperate with Member States, at their request, and with international organizations in monitoring and analysing the pharmaceutical and public health implications of relevant international agreements, including trade agreements.” The TRIPS Agreement is one of the most controversial of the Uruguay Round in terms of content, objectives and possible consequences. This annotated bibliography aims to inform people in the health sector, with no particular legal background, about the impact of globalization and trade agreements on access to drugs, and the growing importance of this issue. It directs the reader to key reports, books and articles from technical and scientific journals, both general references and specific country studies. Details of some useful web sites are also given.
Índice de contenido
Ver el documentoAbbreviations and acronyms
Ver el documentoIntroduction
Ver el documento1. General articles
Abrir esta carpeta y ver su contenido2. Country studies by region
Abrir esta carpeta y ver su contenido3. Electronic information
 

Globalization, Patents and Drugs (Second Edition). An Annotated Bibliography - Health Economics and Drugs Series No. 010

Second Edition (EDM/PAR/2001.1, 52 p.)

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019